scholarly journals High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes

2012 ◽  
Vol 14 (5) ◽  
Author(s):  
Muhammad Riaz ◽  
Anieta M Sieuwerts ◽  
Maxime P Look ◽  
Mieke A Timmermans ◽  
Marcel Smid ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Lymph Node ◽  
Mrna Expression ◽  
Human Breast Cancer ◽  
Poor Prognosis ◽  
Human Breast ◽  
Node Negative ◽  
Estrogen Receptor Positive

scholarly journals Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

2008 ◽  
Vol 105 (35) ◽  
pp. 13021-13026 ◽  
Author(s):  
J. A. Foekens ◽  
A. M. Sieuwerts ◽  
M. Smid ◽  
M. P. Look ◽  
V. de Weerd ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Lymph Node ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Node Negative ◽  
Estrogen Receptor Positive

The Pineal Gland and Breast Cancer: Serum Levels of Melatonin in Patients with Mammary Tumors and Their Relation to Clinical Characteristics

1989 ◽  
Vol 4 (3) ◽  
pp. 157-162 ◽  
Author(s):  
S. Barni ◽  
P. Lissoni ◽  
A. Sormani ◽  
F. Pelizzoni ◽  
F. Brivio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Pineal Gland ◽  
Cancer Patients ◽  
Human Breast Cancer ◽  
Serum Levels ◽  
Breast Cancer Patients ◽  
Human Breast ◽  
Node Negative ◽  
Estrogen Receptor Positive

Several studies have suggested that the pineal gland hormone melatonin may influence the growth of breast cancer. The importance of melatonin blood concentrations in the clinical history of human breast cancer, however, has still to be defined. To further investigate this problem, we used a RIA method to assay serum levels of the pineal hormone in 74 untreated breast cancer patients, clinical stage T1–3 NO-2 MO, and in 46 age-matched healthy women as controls. Mean serum melatonin levels were significantly higher inpatients than in controls. Melatonin concentrations were highest in breast cancer patients with the best prognosis (i.e. estrogen receptor-positive/node-negative cases). Mean levels of melatonin were significantly higher in estrogen receptor-positive patients than in the negative ones. They were also higher in node-negative than in node-positive cases, and in progesterone receptor-positive patients than negative ones, but none of these differences was statistically significant. No difference was observed in relation to menopausal status and to tumor histotype. These results suggest that melatonin plays a role in the hormone-dependency of human breast cancer.

scholarly journals Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis

EBioMedicine ◽  
2015 ◽  
Vol 2 (3) ◽  
pp. 255-263 ◽  
Author(s):  
Hao Tang ◽  
Salwa Sebti ◽  
Rossella Titone ◽  
Yunyun Zhou ◽  
Ciro Isidoro ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Mrna Expression ◽  
Human Breast Cancer ◽  
Poor Prognosis ◽  
Human Breast ◽  
Estrogen Receptor Negative
Sign in / Sign up

Export Citation Format

Share Document